Israel’s Beyond Air (see here previously) has partnered with US-based Beyond Cancer to produce a form of immunotherapy for solid tumors known as ultra-high concentration nitric oxide (UNO). The ultra-high concentration of UNO is undergoing Phase 1 human trials.
Nitric Oxide for cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.